Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Assets (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Return on Assets for 15 consecutive years, with 0.85% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 74.0% to 0.85% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.85%, a 74.0% decrease, with the full-year FY2024 number at 0.09%, down 7.0% from a year prior.
  • Return on Assets was 0.85% for Q3 2025 at Harvard Bioscience, up from 0.88% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2023 to a low of 0.88% in Q2 2025.
  • A 5-year average of 0.16% and a median of 0.04% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: increased 6bps in 2023, then crashed -81bps in 2025.
  • Harvard Bioscience's Return on Assets stood at 0.0% in 2021, then crashed by -1475bps to 0.07% in 2022, then soared by 95bps to 0.0% in 2023, then crashed by -6028bps to 0.2% in 2024, then tumbled by -328bps to 0.85% in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Return on Assets are 0.85% (Q3 2025), 0.88% (Q2 2025), and 0.69% (Q1 2025).